|
Volumn 32, Issue 5, 2005, Pages 431-436
|
In vitro and in vivo evaluation of [123I]-VEGF165 as a potential tumor marker
|
Author keywords
Cancer; Molecular imaging receptor scintigraphy; Vascular endothelial growth factor
|
Indexed keywords
RADIOLIGAND;
TUMOR MARKER;
UNCLASSIFIED DRUG;
VASCULAR ENDOTHELIAL GROWTH FACTOR 165 I 123;
VASCULOTROPIN A;
ANIMAL CELL;
ANIMAL TISSUE;
ARTICLE;
BINDING ASSAY;
CANCER THERAPY;
CARCINOMA IN SITU;
CELL LINE;
CHEMOTHERAPY;
IN VITRO STUDY;
IN VIVO STUDY;
INTERNALIZATION;
MALE;
MELANOMA CELL;
METABOLISM;
MOLECULAR IMAGING;
MOUSE;
NONHUMAN;
NUDE MOUSE;
ONCOLOGY;
PROTEIN EXPRESSION;
WILD TYPE;
ANIMALS;
CELL LINE, TUMOR;
HUMANS;
IODINE RADIOISOTOPES;
MALE;
MELANOMA;
MICE;
RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR;
TISSUE DISTRIBUTION;
VASCULAR ENDOTHELIAL GROWTH FACTOR A;
|
EID: 20744452939
PISSN: 09698051
EISSN: None
Source Type: Journal
DOI: 10.1016/j.nucmedbio.2005.03.005 Document Type: Article |
Times cited : (33)
|
References (12)
|